PL2274002T3 - Kompozycje peptydów bogatych w leucynę i sposoby wydzielania - Google Patents

Kompozycje peptydów bogatych w leucynę i sposoby wydzielania

Info

Publication number
PL2274002T3
PL2274002T3 PL09724382T PL09724382T PL2274002T3 PL 2274002 T3 PL2274002 T3 PL 2274002T3 PL 09724382 T PL09724382 T PL 09724382T PL 09724382 T PL09724382 T PL 09724382T PL 2274002 T3 PL2274002 T3 PL 2274002T3
Authority
PL
Poland
Prior art keywords
leucine
isolation
methods
peptide compositions
rich peptide
Prior art date
Application number
PL09724382T
Other languages
English (en)
Inventor
Loren Ward
Brent Petersen
Stanley Wrobel
Eric Bastian
Original Assignee
Glanbia Nutritionals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glanbia Nutritionals Ireland Ltd filed Critical Glanbia Nutritionals Ireland Ltd
Publication of PL2274002T3 publication Critical patent/PL2274002T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL09724382T 2008-03-26 2009-03-26 Kompozycje peptydów bogatych w leucynę i sposoby wydzielania PL2274002T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3942608P 2008-03-26 2008-03-26
PCT/US2009/038357 WO2009120837A2 (en) 2008-03-26 2009-03-26 Leucine-rich peptide compositions and methods for isolation
EP09724382.8A EP2274002B1 (en) 2008-03-26 2009-03-26 Leucine-rich peptide compositions and methods for isolation

Publications (1)

Publication Number Publication Date
PL2274002T3 true PL2274002T3 (pl) 2015-06-30

Family

ID=41114702

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09724382T PL2274002T3 (pl) 2008-03-26 2009-03-26 Kompozycje peptydów bogatych w leucynę i sposoby wydzielania

Country Status (8)

Country Link
US (3) US20090264363A1 (pl)
EP (1) EP2274002B1 (pl)
JP (2) JP5750039B2 (pl)
CN (1) CN102014947B (pl)
AU (1) AU2009228250B2 (pl)
CA (1) CA2719857C (pl)
PL (1) PL2274002T3 (pl)
WO (1) WO2009120837A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090264363A1 (en) * 2008-03-26 2009-10-22 Ward Loren S Leucine-Rich Peptide Compositions and Methods for Isolation
PL2533791T3 (pl) * 2009-12-21 2017-10-31 Glanbia Nutritionals Ireland Ltd Kompozycja leucyny/peptydu i sposób jej sporządzania
US9445622B2 (en) * 2009-12-21 2016-09-20 Glanbia Nutritionals (Ireland) Ltd. Compositions and methods for improving creatine solubility and stability
CN102669683A (zh) * 2011-03-09 2012-09-19 广州加原医药科技有限公司 海洋鱼多肽在制备缓解视疲劳保健食品的应用
CN103014111B (zh) * 2012-12-13 2014-11-12 内蒙古伊利实业集团股份有限公司 一种富含精氨酸的乳清蛋白水解物及其制备方法
WO2016119629A1 (zh) * 2015-01-30 2016-08-04 江苏大学 多模式超声波强化酶解制备功能多肽的方法
FR3034317B1 (fr) * 2015-03-31 2018-09-14 International Nutrition Research Company Composition pour le traitement d'un etat metabolique pathogene du microbiote intestinal et des maladies derivees
US10188135B2 (en) 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
EP3782917B1 (en) * 2018-04-18 2023-04-26 Mitsubishi Materials Corporation Packaging method for polycrystalline silicon, double-packaging method for polycrystalline silicon, and production method for raw material for monocrystalline silicon
JP2020097537A (ja) * 2018-12-18 2020-06-25 キリンホールディングス株式会社 脳血流を増加させるための組成物
CN115886076B (zh) * 2022-11-26 2024-04-19 黑龙江飞鹤乳业有限公司 含亮氨酸类蛋白反应产物的组合物及在抗肌肉衰减的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152498A (ja) * 1982-03-06 1983-09-10 Terumo Corp 低分子ペプチド混合物の製造方法
JPS60251859A (ja) * 1984-05-30 1985-12-12 Kikkoman Corp 卵白分解物の製造法
US6221423B1 (en) * 1998-04-13 2001-04-24 Protein Technologies Int'l Inc. Short-chained peptide material
NZ508867A (en) * 1998-06-17 2003-11-28 New Zealand Dairy Board Bioactive whey protein hydrolysate
EP1221865B1 (en) * 1999-10-18 2007-01-03 Muscletech Research and Development Inc. Food supplement for increasing lean mass and strength
WO2001090144A2 (en) * 2000-05-22 2001-11-29 Ramot At Tel-Aviv University Ltd. Vip-related peptides for the treatment of sexual disorders in women
AU1142001A (en) * 2000-10-19 2002-04-29 Dsm N.V. Protein hydrolysates
WO2002071854A1 (en) * 2001-03-09 2002-09-19 Unilever N.V. Fermented milk product
ES2540926T3 (es) * 2002-06-04 2015-07-14 Dsm Ip Assets B.V. Hidrolizado de proteínas rico en tripéptidos
CN1784845A (zh) * 2003-02-11 2006-06-07 美商内数位科技公司 使用自适应天线以选择性重新使用共同实体信道时槽于专用信道的系统及方法
ZA200507880B (en) * 2003-05-05 2006-12-27 Unilever Plc Hydrolysed casein product comprising tripeptides IPP and/or VPP
UA89616C2 (ru) * 2003-08-01 2010-02-25 Калпис Ко., Лтд. Гидролизат казеина, способ его получения и применения
US8329646B2 (en) * 2005-11-30 2012-12-11 Nestec S.A. Methods for the treatment of muscle loss
PE20080037A1 (es) * 2006-03-20 2008-04-04 Glanbia Nutritionals Ireland Ltd Composicion alimentaria que comprende lactoferrina
US7777074B2 (en) * 2007-09-18 2010-08-17 Thermolife International, Llc Amino acid compounds
US20090264363A1 (en) * 2008-03-26 2009-10-22 Ward Loren S Leucine-Rich Peptide Compositions and Methods for Isolation

Also Published As

Publication number Publication date
CA2719857C (en) 2019-08-06
AU2009228250A1 (en) 2009-10-01
JP2015110573A (ja) 2015-06-18
CN102014947B (zh) 2016-10-19
WO2009120837A3 (en) 2009-12-30
JP5750039B2 (ja) 2015-07-15
WO2009120837A2 (en) 2009-10-01
US20140171378A1 (en) 2014-06-19
EP2274002B1 (en) 2014-12-03
JP2011517450A (ja) 2011-06-09
CN102014947A (zh) 2011-04-13
AU2009228250B2 (en) 2015-03-19
CA2719857A1 (en) 2009-10-01
US20090264363A1 (en) 2009-10-22
US20160143983A1 (en) 2016-05-26
US9222117B2 (en) 2015-12-29
EP2274002A4 (en) 2012-04-25
JP6227519B2 (ja) 2017-11-08
EP2274002A2 (en) 2011-01-19

Similar Documents

Publication Publication Date Title
PL2274002T3 (pl) Kompozycje peptydów bogatych w leucynę i sposoby wydzielania
IL207340A0 (en) Stabilized protein compositions
IL235618A (en) Preparations and methods for inhibiting pdgfrbeta and vegf
SI3178490T1 (sl) Sestavki proteina F RSV-ja in postopki za pripravo le-teh
IL210153A0 (en) Nutrigenomics methods and compositions
SI3812360T1 (sl) Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo
IL219891A0 (en) Lipopeptide compositions and related methods
IL218084A0 (en) Compounds and compositions as protein kinase inhibitors
PL2470528T3 (pl) Związki i kompozycje jako inhibitory kinazy białkowej
IL212822A0 (en) Anti-cxcr1 compositions and methods
GB0819530D0 (en) Methods and compositions
SI2334177T1 (sl) Peptidna toksinska formulacija
IL208445A0 (en) Compositions and methods for immunotherapy
GB2462761B (en) Protein formulation
EP2249652A4 (en) COMPOSITIONS AND METHODS FOR COMBATING ARACHNIDS
GB0811250D0 (en) Methods and compositions
GB0708529D0 (en) Peptide standards
GB0818399D0 (en) Methods and compositions
GB0816534D0 (en) Compositions and methods
GB0811152D0 (en) Methods and compositions
GB0803464D0 (en) Methods and compositions
GB0803594D0 (en) Protein formulation
GB0807929D0 (en) Protein formulation